ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Evaluating PDQ Evaluation

September 1, 1989

In Brief: Simone, LoBuglio Lead AACI; AMA Honors B.J. Kennedy; FDA Meet Patient Advocates

July 31, 1992

In Brief: Shingleton “Unretires” As Director Of Duke Center; O’Brien Interim Head At USC When Hammond Leave

July 24, 1981

Chemopreventive Phase I, Preclinical Studies Concept Approved

May 13, 1983

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

Funding Opportunity.

July 12, 2002